Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil

被引:23
|
作者
Achatz, Maria Isabel [1 ]
Caleffi, Maira [2 ,3 ]
Guindalini, Rodrigo [4 ,5 ]
Marques, Renato Moretti [6 ,7 ]
Nogueira-Rodrigues, Angelica [8 ,9 ,10 ]
Ashton-Prolla, Patricia [11 ,12 ]
机构
[1] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
[2] Nucleo Mama Porto Alegre, Porto Alegre, RS, Brazil
[3] Assoc Hosp Moinhos de Vento, Porto Alegre, RS, Brazil
[4] Rede DOr Sao Luiz, Oncol DOr, Rio De Janeiro, Brazil
[5] Univ Sao Paulo, Ctr Invest Translac Oncol, Inst Canc Estado Sao Paulo, Hosp Clin,Fac Med, Sao Paulo, Brazil
[6] Hosp Israelita Albert Einstein, Programa Saude Mulher, Sao Paulo, Brazil
[7] Hosp Israelita Albert Einstein, Ctr Oncol & Hematol, Sao Paulo, Brazil
[8] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[9] Grp Brasileiro Oncol Ginecol, Belo Horizonte, MG, Brazil
[10] DOM Oncol, Divinopolis, MG, Brazil
[11] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil
[12] Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil
关键词
BRCA MUTATION CARRIERS; NIPPLE-SPARING MASTECTOMY; COST-EFFECTIVENESS; HIGH-RISK; CONTRALATERAL MASTECTOMY; MAINTENANCE THERAPY; WOMEN; PANEL; TP53; SURVIVAL;
D O I
10.1200/JGO.19.00170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEThe objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC.METHODSA selected panel of Brazilian experts in fields related to HBOC was provided with a series of relevant questions to address before the multiday conference. During this conference, each narrative was discussed and edited by the entire group, through numerous drafts and rounds of discussion, until a consensus was achieved.RESULTSThe authors propose specific and realistic recommendations for improving access to early diagnosis, risk management, and cancer care of HBOC specific to Brazil. Moreover, in creating these recommendations, the authors strived to address all the barriers and impediments mentioned in this article.CONCLUSIONThere is a great need to expand hereditary cancer testing and counseling in Brazil, and changing current policies is essential to accomplishing this goal. Increased knowledge and awareness, together with regulatory actions to increase access to this technology, have the potential to improve patient care and prevention and treatment efforts for patients with cancer across the country. (c) 2020 by American Society of Clinical Oncology
引用
收藏
页码:439 / 452
页数:14
相关论文
共 50 条
  • [31] Hereditary breast and ovarian cancer syndrome
    Tamaki, Yasuhiro
    CANCER SCIENCE, 2018, 109 : 778 - 778
  • [32] Pharmacoprevention for hereditary breast and ovarian cancer
    Cazzaniga, Massimiliano
    Bonanni, Bernardo
    MINERVA GINECOLOGICA, 2016, 68 (05): : 517 - 535
  • [33] Clinical findings and medical management of hereditary breast-ovarian cancer without molecular diagnosis in a referral cancer center.
    Morales-Vasquez, Flavia
    Noe Lopez-Basave, Horacio
    Caballero, Hector M.
    Mendez Herrera, Maria del Carmen
    Tirado Gomez, Laura Leticia
    Gallardo Rincon, Dolores
    Ruvalcaba Limon, Eva
    Herrera, MaryTere
    Urzua, Lorena
    Namendys-Silva, Silvio A.
    Vidal, Silvia
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] A case of simultaneous breast cancer and ovarian cancer based on a hereditary breast and ovarian cancer syndrome
    Kotaka, Saki
    Yasui, Hiroaki
    Tsubouchi, Hirofumi
    Mori, Masahiko
    Kotani, Haruru
    Yoshimura, Akiyo
    Ouchi, Akira
    Okuno, Masataka
    Komori, Koji
    Shimizu, Yasuhiro
    Suzuki, Shiro
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (04): : 814 - 821
  • [35] Management of hereditary breast cancer
    Eccles, DM
    Simmonds, P
    Goddard, J
    Coultas, M
    Lalloo, F
    Evans, G
    Haites, N
    DISEASE MARKERS, 1999, 15 (1-3) : 187 - 189
  • [36] Identification and Management of Women at High Risk for Hereditary Breast/Ovarian Cancer Syndrome
    Ozanne, Elissa M.
    Loberg, Andrea
    Hughes, Sherwood
    Lawrence, Christine
    Drohan, Brian
    Semine, Alan
    Jellinek, Michael
    Cronin, Claire
    Milham, Frederick
    Dowd, Dana
    Block, Caroline
    Lockhart, Deborah
    Sharko, John
    Grinstein, Georges
    Hughes, Kevin S.
    BREAST JOURNAL, 2009, 15 (02): : 155 - 162
  • [37] Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
    Pruthi, Sandhya
    Gostout, Bobbie S.
    Lindor, Noralane M.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (12) : 1111 - 1120
  • [38] HEREDITARY BREAST AND HEREDITARY OVARIAN CANCER: IMPLICATIONS FOR THE ONCOLOGY NURSE
    Beamer, Laura Curr
    SEMINARS IN ONCOLOGY NURSING, 2019, 35 (01) : 47 - 57
  • [39] Imaging Recommendations for Diagnosis, Staging, and Management of Hereditary Malignancies
    Majithia, Jinita
    Mahajan, Abhishek
    Vaish, Richa
    Prakash, Gagan
    Patwardhan, Saket
    Sarin, Rajiv
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (03) : 287 - 301
  • [40] IDENTIFICATION AND SURVEILLANCE OF HEREDITARY BREAST CANCER: THE EXPERIENCE OF THE 'ITALIAN NETWORK ON HEREDITARY BREAST AND OVARIAN CANCER'
    Cortesi, Laura
    Turchetti, Daniela
    D'Andrea, Emma
    Bevilacqua, Generoso
    Piga, Andrea
    Contegiacomo, Alma
    Sismondi, Piero
    Cama, Alessandro
    Belli, Paolo
    Federico, Massimo
    Venuta, Salvatore
    ANNALS OF ONCOLOGY, 2004, 15 : 26 - 26